Quanome Technologies, Inc. QNME
0.74
(0.07)
(8.64%)
as of 25 Sep
- Market cap
- $26.9M
- P/E
- 0.0×
Follow QNME
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
| (51.41%) | (70.96%) | (99.65%) | (301.02%) |
+8 more TTM periods Free account |
|
| (26.63%) | (28.74%) | (35.78%) | (44.46%) | ||
ROIC |
(28.34%) | (25.14%) | (106.40%) | 0.00% | |
Return on Tangible Assets |
(27.85%) | (44.01%) | (94.66%) | (678.32%) | |
Average Days of Receivables |
110.27 | 189.49 | 175.77 | 33.42 | |
Free Cash Flow per Share |
(0.14) | (0.27) | (0.36) | (0.43) | |
Free Cash Flow |
(4.72) | (5.19) | (5.27) | (3.26) | |
Capital Expenditures |
— | — | — | (0.60) | |
Piotroski F-Score |
4.00 | 4.00 | 1.00 | 2.00 | |
| Other line items | |||||
Cash ROIC |
(31.35%) | (36.53%) | (44.06%) | (30.09%) | |
Accounts Receivable Turnover |
5.31 | 3.33 | 3.32 | 7.24 | |
Accounts Payable Turnover |
13.74 | 8.09 | 9.41 | 12.39 | |
Inventory Turnover |
151.26 | 264.62 | 0.00 | 0.00 | |
Average Days of Payables |
19.83 | 63.53 | 59.05 | 24.92 | |
Days of Inventory on Hand |
0.45 | 2.55 | 2.95 | 2.36 | |
Tax Rate |
0.05 | 0.06 | 0.07 | 0.02 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
46.20% | 40.52% | 41.72% | 43.87% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.28 | 1.06 | 1.00 | 0.51 | |
Depreciation/Fixed assets |
2.96 | 1.79 | 1.29 | 2.64 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (1.42) | |
Revenue per Share |
0.70 | 1.19 | 1.34 | 2.35 | |
Operating CF per Share |
(0.14) | (0.27) | (0.36) | (0.35) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.08) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.03 | |
Net Profit Margin |
(15.35%) | (21.12%) | (26.59%) | (29.49%) |
Columns are period end dates